Aspira Pathlab and Diagnostics Ltd
Mon 21/09/2026,10:53:0 | BSE : ASPIRA
Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.
Market Data
Essential tool: analyze, trade, manage, decide.
Open
₹ 120.75
Previous Close
₹ 115.00
Volume
6127
Mkt Cap ( ₹ Cr)
₹ 124.29
High
₹ 120.75
Low
₹ 120.75
52 Week High
₹ 135.88
52 Week Low
₹ 49.00
Book Value Per Share
₹ 11.85
Dividend Yield
₹ 0.00
Face Value
₹₹10.00
What's Your Call?
Collective community sentiment on Aspira Pathlab and Diagnostics Ltd
Your Vote -
Buy
50.00%
Hold
0.00%
Sell
50.00%
50.00%
4 users have voted
Option Chain
Analyzes market sentiment, predicts Aspira Pathlab and Diagnostics Ltd' movement.
NO_RECORD_FOUND
News
Media spotlight triggers stock stock attention, sentiment.
-
Aspira Pathlab & Dia - Announcement Under Regulation 30_Constitution Of Right Issue Committee
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Raising of Funds
-
Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th September 2026
-
Aspira Pathlab & Dia - Board Meeting Intimation for To Consider Approve The Proposal For Raising Funds Through The Issuance O
-
Aspira Pathlab & Dia - Letters Dispatched To Non-Email Shareholders
-
Aspira Pathlab & Dia - Reg. 34 (1) Annual Report.
-
Aspira Pathlab & Dia - Notice Convening 53Rd Annual General Meeting To Be Held On Friday, September 25, 2026 At 02.00 P.M Thr
-
Aspira Pathlab & Dia - Intimation Of Book Closure Date, Notice Of The 53Rd Annual General Meeting And E-Voting Date
-
Aspira Pathlab & Dia posts Q1 net loss of Rs 0.04 cr
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Management
-
Aspira Pathlab & Dia - Unaudited Standalone Financial Results For The Quarter Ended June 30, 2026
-
Aspira Pathlab & Dia - Board Meeting Outcome for Outcome Of Board Meeting Held On 12Th August 2026
-
Aspira Pathlab & Dia - Board Meeting Intimation for Approval Of Un-Audited Financial Result (Standalone) For The First Quarte
-
Aspira Pathlab & Dia - Resignation Of Internal Auditor
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Resignation of Chief Executive Officer (CEO)
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Resignation of Managing Director
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Resignation of Director
-
Aspira Pathlab & Dia - Announcement under Regulation 30 (LODR)-Change in Directorate
-
Aspira Pathlab & Dia has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2026
-
Aspira Pathlab & Dia - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Key fundamentals
Evaluate the intrinsic value of Aspira Pathlab and Diagnostics Ltd stockÂ
| Name | March-26 | March-25 | March-24 | March-23 | March-22 |
|---|---|---|---|---|---|
| Assets | 13.5822 | 13.4227 | 11.2205 | 13.7122 | 13.6482 |
| Liabilities | 13.5822 | 13.4227 | 11.2205 | 13.7122 | 13.6482 |
| Equity | 10.293 | 10.293 | 10.293 | 10.293 | 10.293 |
| Gross Profit | 1.4632 | 3.5249 | -1.1868 | 1.5932 | 6.3731 |
| Net Profit | 0.0513 | 2.0726 | -2.6722 | -0.0887 | 4.4594 |
| Cash From Operating Activities | 1.4537 | 1.877 | 1.053 | -0.0121 | 2.031 |
| NPM(%) | 0.2 | 9.42 | -20.23 | -0.61 | 22.81 |
| Revenue | 24.982 | 21.999 | 13.2049 | 14.4569 | 19.5419 |
| Expenses | 23.5188 | 18.4741 | 14.3917 | 12.8637 | 13.1688 |
| ROE(%) | 0.42 | 16.99 | -21.91 | -0.72 | 36.57 |
Corporate Action
| XD-Date | Dividend-Amount | Dividend-% | Dividend Yield(%GE) | Price on that day |
|---|
Peers
Other companies within the same industry or sector that are comparable to Aspira Pathlab and Diagnostics Ltd
| Company | Price | Price (% change) | pe(x) | EV/EBITDA(x) | ROE(%) | ROCE(%) |
|---|---|---|---|---|---|---|
| Albert David Ltd | 797.00 | -5.93 | 21.15 | 62.51 | -26.19 | 0.60 |
| Lotus Eye Hospital and Institute Ltd | 116.00 | 2.97 | 1644.29 | 227.78 | 0.39 | 0.00 |
| Bharat Immunological and Biologicals Corporation Ltd | 14.20 | 0.28 | 0.00 | 472.95 | -39.50 | 0.00 |
| Astec Lifesciences Ltd | 718.00 | -1.31 | 0.00 | 244.06 | -363.14 | 0.00 |
Company Info
Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016. 2025-The Company Acquire 100% of stake in Aspira DNA Diagnostics Gujarat LLP.
Aspira Pathlab & Diagnostics Ltd. Was incorporated as 03td July in the year 1973 in the name of 'industrial Gas & Steel Products (India) Ltd.' It has changed its name to 'Utkal Soap Products Ltd.' on 4th February, 1980. USPL with the main object of dealing in gases Products & Steel Products, Subsequent to change of name of the Company, it has changed its object in 1980 to manufacture laundry soaps for Hindustan Lever Limited, having its factory at Sambalput - Orissa. the Company has stopped Manufacturing production since November, 2004 as the job work for Hindustan Lever Limited was not renewed because of additional duties levied by the Government, it has became unviable proposal & the Company has disposed off all its assets in 2005. The employees have been paid off their dues as per settlement with the Labour union, Since 2005.The Company has changed its object clause on 10th August, 2016 & Ventured into diagnostic centers laboratories etc, & stated generating income from December, 2016 onwards. The Company changed its name to 'Aspira Parthlab & Diagnostics Ltd.' on 16th November, 2016. 2025-The Company Acquire 100% of stake in Aspira DNA Diagnostics Gujarat LLP.
Read More
Parent Organisation
Aspira Pathlab & Diagnostics Ltd.
Founded
03/07/1973
Managing Director
Dr.Pankaj J Shah
NSE Symbol
FAQ
The current price of Aspira Pathlab and Diagnostics Ltd is
The 52-week high for Aspira Pathlab and Diagnostics Ltd is
The market capitalization of Aspira Pathlab and Diagnostics Ltd is currently This value can fluctuate based on stock price movements and changes in the number of shares outstanding.
To buy Aspira Pathlab and Diagnostics Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.
To invest in Aspira Pathlab and Diagnostics Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Aspira Pathlab and Diagnostics Ltd shares.
The CEO of Aspira Pathlab and Diagnostics Ltd is Dr.Pankaj J Shah, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.
